Identification of Intrinsic Drug Resistance and Its Biomarkers in High-Throughput Pharmacogenomic and CRISPR Screens-Reference-Cited by-同舟云学术

Identification of Intrinsic Drug Resistance and Its Biomarkers in High-Throughput Pharmacogenomic and CRISPR Screens

Published:2020-08 Issue:5 Volume:1 Page:100065
ISSN:2666-3899
Container-title:Patterns
language:en
Short-container-title:Patterns

Author:

Ayestaran Iñigo,Galhoz Ana^ORCID,Spiegel Elmar^ORCID,Sidders Ben,Dry Jonathan R.^ORCID,Dondelinger Frank^ORCID,Bender Andreas,McDermott Ultan^ORCID,Iorio Francesco^ORCID,Menden Michael P.^ORCID

Funder

Open Targets

CRUK

AstraZeneca

Publisher

Elsevier BV

Subject

General Decision Sciences

Reference47 articles.

1. Towards precision medicine;Ashley;Nat. Rev. Genet.,2016

2. Evolutionary determinants of cancer;Greaves;Cancer Discov.,2015

3. A view on drug resistance in cancer;Vasan;Nature,2019

4. Biomarker development in the precision medicine era: lung cancer as a case study;Vargas;Nat. Rev. Cancer,2016

5. The NCI60 human tumour cell line anticancer drug screen;Shoemaker;Nat. Rev. Cancer,2006

Cited by 8 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Glioblastoma stem cells show transcriptionally correlated spatial organization;2024-08-28

2. Pharmacological agents targeting drug-tolerant persister cells in cancer;Pharmacological Research;2024-05

3. Siglec-7 glyco-immune binding mAbs or NK cell engager biologics induce potent antitumor immunity against ovarian cancers;Science Advances;2023-11-03

4. Comparative kinase and cancer cell panel profiling of kinase inhibitors approved for clinical use from 2018 to 2020;Frontiers in Oncology;2022-09-14

5. Recent Advances and Therapeutic Strategies Using CRISPR Genome Editing Technique for the Treatment of Cancer;Molecular Biotechnology;2022-08-23